Lung infections after cancer chemotherapy

Sandro Vento, Francesca Cainelli, Zelalem Temesgen

Research output: Contribution to journalReview article

71 Citations (Scopus)

Abstract

Lung infections can be severe consequences of chemotherapy-induced immune defects. Aetiological causes of infection include bacteria (most commonly Pseudomonas aeruginosa, Stenotrophomonas maltophilia, and Nocardia species), viruses (eg, respiratory syncytial virus, parainfluenza virus, influenza virus A and B, and cytomegalovirus), and fungi (eg, Aspergillus, Fusarium, and Mucorales species, and Pneumocystis jirovecii). Most infections are caused by bacteria (especially Gram negative), but viruses are being increasingly identified. Diagnosis is difficult and frequently time-consuming. Treatment can be ineffective for many patients, particularly those with fungal infection. The greatest hope for the future is the availability of more targeted anticancer drugs that have fewer side-effects on the immune system.

Original languageEnglish
Pages (from-to)982-992
Number of pages11
JournalThe Lancet Oncology
Volume9
Issue number10
DOIs
Publication statusPublished - Oct 2008
Externally publishedYes

Fingerprint

Viruses
Drug Therapy
Lung
Mucorales
Infection
Stenotrophomonas maltophilia
Influenza B virus
Paramyxoviridae Infections
Pneumocystis carinii
Nocardia
Neoplasms
Respiratory Syncytial Viruses
Mycoses
Influenza A virus
Fusarium
Aspergillus
Gram-Negative Bacteria
Cytomegalovirus
Pseudomonas aeruginosa
Immune System

ASJC Scopus subject areas

  • Oncology

Cite this

Lung infections after cancer chemotherapy. / Vento, Sandro; Cainelli, Francesca; Temesgen, Zelalem.

In: The Lancet Oncology, Vol. 9, No. 10, 10.2008, p. 982-992.

Research output: Contribution to journalReview article

Vento, Sandro ; Cainelli, Francesca ; Temesgen, Zelalem. / Lung infections after cancer chemotherapy. In: The Lancet Oncology. 2008 ; Vol. 9, No. 10. pp. 982-992.
@article{b991b53a8813436cb71618278d38f633,
title = "Lung infections after cancer chemotherapy",
abstract = "Lung infections can be severe consequences of chemotherapy-induced immune defects. Aetiological causes of infection include bacteria (most commonly Pseudomonas aeruginosa, Stenotrophomonas maltophilia, and Nocardia species), viruses (eg, respiratory syncytial virus, parainfluenza virus, influenza virus A and B, and cytomegalovirus), and fungi (eg, Aspergillus, Fusarium, and Mucorales species, and Pneumocystis jirovecii). Most infections are caused by bacteria (especially Gram negative), but viruses are being increasingly identified. Diagnosis is difficult and frequently time-consuming. Treatment can be ineffective for many patients, particularly those with fungal infection. The greatest hope for the future is the availability of more targeted anticancer drugs that have fewer side-effects on the immune system.",
author = "Sandro Vento and Francesca Cainelli and Zelalem Temesgen",
year = "2008",
month = "10",
doi = "10.1016/S1470-2045(08)70255-9",
language = "English",
volume = "9",
pages = "982--992",
journal = "The Lancet Oncology",
issn = "1470-2045",
publisher = "Lancet Publishing Group",
number = "10",

}

TY - JOUR

T1 - Lung infections after cancer chemotherapy

AU - Vento, Sandro

AU - Cainelli, Francesca

AU - Temesgen, Zelalem

PY - 2008/10

Y1 - 2008/10

N2 - Lung infections can be severe consequences of chemotherapy-induced immune defects. Aetiological causes of infection include bacteria (most commonly Pseudomonas aeruginosa, Stenotrophomonas maltophilia, and Nocardia species), viruses (eg, respiratory syncytial virus, parainfluenza virus, influenza virus A and B, and cytomegalovirus), and fungi (eg, Aspergillus, Fusarium, and Mucorales species, and Pneumocystis jirovecii). Most infections are caused by bacteria (especially Gram negative), but viruses are being increasingly identified. Diagnosis is difficult and frequently time-consuming. Treatment can be ineffective for many patients, particularly those with fungal infection. The greatest hope for the future is the availability of more targeted anticancer drugs that have fewer side-effects on the immune system.

AB - Lung infections can be severe consequences of chemotherapy-induced immune defects. Aetiological causes of infection include bacteria (most commonly Pseudomonas aeruginosa, Stenotrophomonas maltophilia, and Nocardia species), viruses (eg, respiratory syncytial virus, parainfluenza virus, influenza virus A and B, and cytomegalovirus), and fungi (eg, Aspergillus, Fusarium, and Mucorales species, and Pneumocystis jirovecii). Most infections are caused by bacteria (especially Gram negative), but viruses are being increasingly identified. Diagnosis is difficult and frequently time-consuming. Treatment can be ineffective for many patients, particularly those with fungal infection. The greatest hope for the future is the availability of more targeted anticancer drugs that have fewer side-effects on the immune system.

UR - http://www.scopus.com/inward/record.url?scp=52749096517&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=52749096517&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(08)70255-9

DO - 10.1016/S1470-2045(08)70255-9

M3 - Review article

VL - 9

SP - 982

EP - 992

JO - The Lancet Oncology

JF - The Lancet Oncology

SN - 1470-2045

IS - 10

ER -